Abstract:Abstract Autophagy is an evolutionarily conserved process involving degradation of cellular components in lysosomes to maintain protein and organelle quality control, and temporarily sustain cell viability in response to stressful stimuli. Several studies have demonstrated the dual role of autophagy in tumorigenesis as both a tumor suppressor and a protector of cancer cell survival under stress. It is well recognized that anticancer therapies, such as chemotherapy and irradiation (RT), induce autophagy as a pro-survival response, likely resulting in therapeutic resistance. Therefore, concurrent autophagy inhibition as a chemo- and RT-sensitizer has generated great interest in cancer therapy. We generated Beclin1+/+ and Beclin1+/- immortalized mouse mammary epithelial cells (iMMECs) stably expressing the apoptosis inhibitor BCL-2 and the autophagy marker EGFP-LC3 to investigate how acute autophagy inhibition and chronic autophagy deregulation impact tumor sensitivity to anticancer drugs commonly used against breast cancer. We also used human cancer cell lines, including MCF-7, PANC-1, MIA PaCa-2 and HCT-116 cells, to explore whether pharmacologic autophagy inhibition or genetic knockdown of autophagy regulators exhibits a synergistic anticancer effect with newer antineoplastic drugs, such as mTOR inhibitors (CCI-779 and RAD001) and novel antimicrotubule agents (ixabepilone). Treatment efficacy was evaluated by clonogenic survival and cytotoxicity assays in 2D- and 3D-epithelial cell culture in vitro and by tumor responsiveness assays in mice in vivo. Autophagy inhibition sensitized Beclin1+/+ apoptosis-defective iMMECs to doxorubicin, but not to paclitaxel, and had an even greater impact on autophagy-deficient cells. Moreover, autophagy inhibition via choloroquine or Beclin1 knockdown enhanced the treatment efficacy of mTOR inhibitors on MCF-7, PANC-1, MIA PaCa-2 and HCT116 cells in vitro and in xenograft tumors in nude mice in vivo. These studies provide insight into how autophagy functional status in tumors impacts treatment responsiveness and into how to best incorporate pharmacologic autophagy modulation in the decision tree for cancer treatment. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 102nd Annual Meeting of the American Association for Cancer Research; 2011 Apr 2-6; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2011;71(8 Suppl):Abstract nr 3545. doi:10.1158/1538-7445.AM2011-3545

Abstract C150: CaMKKβ-mediated Phosphorylation of Beclin 1 Regulates Autophagy and Cell Differentiation in Neuroblastoma Cells.

CaMKII-mediated Beclin 1 Phosphorylation Regulates Autophagy That Promotes Degradation of Id and Neuroblastoma Cell Differentiation

AMPK Regulates Autophagy by Phosphorylating BECN1 at Threonine 388.

The molecular mechanisms underlying BCR/ABL degradation in chronic myeloid leukemia cells promoted by Beclin1-mediated autophagy.

Knockdown of Beclin-1 Impairs Epithelial-Mesenchymal Transition of Colon Cancer Cells.

Beclin 1 Bridges Autophagy, Apoptosis and Differentiation

CAMK2G Promotes Neuronal Differentiation and Inhibits Migration in Neuroblastoma

Abstract 3545: Autophagy Inhibition As a Therapeutic Strategy in Cancer

The Pivotal Role of C-Jun Nh2-Terminal Kinase-Mediated Beclin 1 Expression During Anticancer Agents-Induced Autophagy in Cancer Cells

Acetylation of Beclin 1 Inhibits Autophagosome Maturation and Promotes Tumour Growth

Roles of Autophagy and Mtor Signaling in Neuronal Differentiation of Mouse Neuroblastoma Cells.

Phosphoglycerate Kinase 1 Phosphorylates Beclin1 to Induce Autophagy

Beclin-1: autophagic regulator and therapeutic target in cancer.

XIAP and Ciap1 Amplifications Induce Beclin 1-Dependent Autophagy Through NFκB Activation.

High Mobility Group Box 1-Mediated Autophagy Promotes Neuroblastoma Cell Chemoresistance

Targeting autophagy and beyond: Deconvoluting the complexity of Beclin-1 from biological function to cancer therapy

MAP kinase-dependent autophagy controls phorbol myristate acetate-induced macrophage differentiation of HL-60 leukemia cells

Beclin 1 Phosphorylation - at the Center of Autophagy Regulation

Autophagy pathway is required for IL-6 induced neuroendocrine differentiation and chemoresistance of prostate cancer LNCaP cells

CK1δ/ε inhibition induces ULK1-mediated autophagy in tumorigenesis

Post-translational modifications of Beclin 1 provide multiple strategies for autophagy regulation